Mednax Inc (MD)

Net profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands -103,613 -60,408 66,335 130,964 -9,580
Revenue US$ in thousands 2,012,920 1,994,640 1,972,020 1,911,190 1,733,950
Net profit margin -5.15% -3.03% 3.36% 6.85% -0.55%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $-103,613K ÷ $2,012,920K
= -5.15%

The net profit margin of Mednax Inc has shown varying trends over the past five years. In December 2020, the company reported a negative net profit margin of -0.55%, indicating that its expenses outweighed its revenue, resulting in a loss. However, by December 2021, the net profit margin significantly improved to 6.85%, reflecting a more efficient management of costs and increased profitability.

In December 2022, the net profit margin slightly decreased to 3.36%, suggesting potential challenges in maintaining the same level of profitability achieved in the previous year. This trend continued in December 2023, with a further decline to -3.03%, indicating a reversal to a loss-making position.

By December 2024, the net profit margin deteriorated even further to -5.15%, signaling ongoing challenges for Mednax Inc in generating profits relative to its revenue. Overall, the fluctuating net profit margins highlight the company's need to address its cost structure and revenue generation strategies to enhance long-term financial sustainability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Net profit margin
Mednax Inc
MD
-5.15%
Encompass Health Corp
EHC
8.48%
Select Medical Holdings
SEM
4.13%